What's Happening?
UFC fighter Manon Fiorot has been issued a three-month suspension for violating the promotion's anti-doping policy. The suspension, announced by UFC officials, stems from a positive test for low levels of ostarine, a prohibited substance classified as an Anabolic
Agent. The substance was detected in an in-competition sample collected on September 12, 2026, following her bout against Alexa Grasso at UFC Noche. Fiorot, who lost the fight, provided full cooperation during the investigation. She explained that her nutritionist supplied several new dietary supplements during fight week, which she stopped using after the event. Combat Sports Anti-Doping (CSAD) officials determined that the positive test was consistent with inadvertent exposure from contaminated supplements, rather than intentional use, and that the low levels of ostarine did not provide a significant performance advantage. Her suspension began on October 19, 2026, and she will be eligible to compete again on or after January 19, 2027.
Why It's Important?
This incident highlights the ongoing challenges within professional sports regarding supplement contamination and anti-doping regulations. For athletes like Fiorot, who are subject to strict anti-doping policies, the inadvertent consumption of prohibited substances through contaminated supplements can lead to significant career disruptions, even without intent to cheat. The UFC's decision to issue a three-month suspension, rather than the potential six-month ban, reflects the organization's consideration of the circumstances, including Fiorot's full cooperation and the determination of inadvertent exposure. This case underscores the critical need for athletes and their support teams to exercise extreme caution and diligence in vetting all dietary supplements to avoid similar violations, which can damage reputations and careers, regardless of intent. It also reinforces the role of anti-doping agencies in maintaining fair play and athlete safety within competitive sports.
What's Next?
Manon Fiorot's suspension will conclude on January 19, 2027, at which point she will be eligible to return to competition. As of now, she has not been booked for another fight in the octagon. Her return will likely involve careful planning with her team to ensure strict adherence to anti-doping guidelines, particularly concerning dietary supplements. The incident may prompt other UFC fighters and their nutritionists to review their supplement protocols more rigorously to prevent similar accidental violations. The UFC and CSAD will continue to enforce their anti-doping policy, and this case serves as a precedent for how inadvertent exposure cases are handled, emphasizing cooperation during investigations as a mitigating factor for sanctions.
Beyond the Headlines
The case of Manon Fiorot extends beyond a simple doping violation, touching upon the broader ethical and practical considerations of supplement use in high-performance sports. The fact that ostarine, a selective androgen receptor modulator, was found in trace amounts due to contaminated supplements, raises questions about the regulation and quality control of the supplement industry. Athletes often rely on nutritionists and supplement providers, placing immense trust in their recommendations. This incident underscores the potential for innocent athletes to be penalized due to external factors, prompting a deeper discussion on shared responsibility among athletes, their support staff, and supplement manufacturers. It also highlights the continuous cat-and-mouse game between anti-doping agencies and those who might intentionally or unintentionally introduce prohibited substances into the sporting ecosystem, emphasizing the need for robust testing and transparent investigative processes.













